Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- UCB Japan Goes Solo on E Keppra Marketing as Otsuka Deal Ends
October 2, 2020
- Fujifilm to Manufacture VLP Therapeutics’ COVID-19 Vaccine
October 2, 2020
- ASKA, Kyorin to Jointly Develop Benign Prostatic Hyperplasia Drug
October 1, 2020
- Eisai, Seikagaku Tie Up on Osteoarthritis Med in South Korea
October 1, 2020
- Mitsubishi Tanabe Recalls Theodur on Failed Dissolution Test
October 1, 2020
- Shionogi Grabs Global Rights for Univ. of Tokyo Spin-Off’s Novel S. Pneumoniae Nasal Vaccine
October 1, 2020
- After Photoimmunotherapy Nod, Rakuten’s Mikitani Says Company Is Finally at Start Line
September 30, 2020
- Fetroja Approved for Nosocomial Pneumonia in US
September 30, 2020
- Fujifilm Kyowa Kirin’s Avastin Biosimilar Approved in Europe
September 30, 2020
- Torii Enjoys Stellar Performance from Corectim, 1st JAK Med for Atopic Dermatitis
September 30, 2020
- Alnylam Seeks Japan Approval of RNAi Drug Givosiran for Acute Hepatic Porphyrias
September 30, 2020
- JCR Files Sakigake-Designated Pabinafusp Alfa for Hunter Syndrome
September 30, 2020
- 2nd GPCR-Targeted Candidate Enters Clinic under Sosei/Pfizer’s Drug Discovery Alliance
September 29, 2020
- Otsuka Files Japan NDA for Atopic Dermatitis Drug Difamilast
September 29, 2020
- AbbVie Files New Dosage Forms for Skyrizi in Japan
September 29, 2020
- Approval Now in Hand, CureApp Looks at Collaborations with Drug Makers to Push Therapeutic Apps
September 29, 2020
- Sawai, Susmed Pair Up in Digital Healthcare Field
September 28, 2020
- Shionogi Delays Saliva-Based COVID-19 Test Launch to December
September 25, 2020
- Astellas, Univ. of Pittsburgh Ink Research Pact for Dry AMD
September 25, 2020
- Taiho Hooks Up with MD Anderson on Refractory Cancers
September 25, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…